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A B S T R A C T Dietary components responsible for the
regulation of somatomedin-C in humans were assessed
in five adult volunteers of normal weight who were
fasted for 5 d on three occasions, then refed three diets
of differing composition. The serum somatomedin-C
decreased from a mean prefasting value of 1.85±0.39
U/ml (±1 SD) to 0.67±0.16 U/ml at the end of fasting
(P < 0.005). After refeeding for 5 d with a normal diet,
the mean serum somatomedin-C increased to 1.26±0.20
U/ml. A protein-deficient (32% of control), isocaloric
diet resulted in a significantly smaller increase, to a
mean value of 0.90±0.24 U/ml (P < 0.05). A diet de-
ficient in both protein and energy led to a further fall
in mean serum somatomedin-C concentrations to
0.31±0.06 U/mI. The changes in somatomedin-C dur-
ing fasting and refeeding correlated significantly with
mean daily nitrogen balance (r = 0.90).
We conclude that both protein and energy intake
are regulators of serum somatomedin-C concentrations
in adult humans, and energy intake may be of greater
importance. The correlation between changes in so-
matomedin-C and nitrogen balance suggests that the
former are directly related to changes in protein syn-
thesis and may be helpful in assessing the response to
nutritional therapy.
INTRODUCTION
Nutritional status is one of the most important deter-
minants of somatomedin concentrations in blood (1).
Bioassayable somatomedin levels are low in children
with protein-calorie malnutrition (2, 3) and in starved
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rats (4). Using a sensitive, specific radioimmunoassay
(5), we have reported that obese human subjects fasted
for 10 d have a marked decline in somatomedin-C (6),
one member of the somatomedin family of peptides.
In these subjects the fall in somatomedin-C correlated
with the change in urea nitrogen excretion, suggesting
that the concentration of immunoreactive somato-
medin-C might be a useful indicator of nutritional
status.
The dietary components involved in the modulation
of serum somatomedin concentrations in humans have
not been defined. Phillips et al. (7) have reported that
refeeding starved rats with a balanced, energy-defi-
cient diet limited the increase in bioassayable soma-
tomedin, and that when energy is adequate, the rate
of recovery of somatomedin is dependent on the dis-
tribution of nutrients in the diet. Using the specific
somatomedin-C radioimmunoassay, Prewett et al. (8)
observed that optimal intake of both protein and en-
ergy were needed to maintain somatomedin-C levels
in young growing rats. The studies reported here were
undertaken in humans to determine the relative im-
portance of dietary intake of protein and energy in
the regulation of somatomedin-C and to determine
whether any relationship exists between somatomedin-
C and nitrogen balance during refeeding.
METHODS
Five healthy volunteers, two men and three women who
were within 15% of ideal body weight (9) participated in
the study. The subjects, ages 23-34 yr, were studied in the
Clinical Research Unit of the North Carolina Memorial Hos-
pital, but were allowed to maintain their normal activities
outside the hospital at times not required for feeding or
blood collections. Subjects were asked to maintain their usual
activity, but not to engage in strenuous exercise. After giving
informed consent, each subject was fasted for 5 d, being
permitted to take water ad lib. and 20 meq KCI daily. Fol-
lowing each 5-d fast, they were refed for 5 d with one of
three different test diets. At the end of the 5-d refeeding
period they were given a diet that approximated home intake
for 15 d or more, before beginning another fast-refeed cycle.
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TABLE I
Composition of Refeeding Diets
g protein/kg body wt kcal/kg body wt Total calories
Normal diet 1.35±0.07 35.3±0.6 1,800-2,610
Low protein, isocaloric to the
normal diet 0.43±0.05 35.1±0.7 1,797-2,579
Low protein, calorie deficient 0.40±0.03 10.8±0.2 552-799
The refeeding diets were assigned in random order after
each fast and were composed as shown in Table I. Dietary
protein and energy content were determined from standard
food value tables (10).
During fasting, body weight and urinary ketones were
measured daily to insure adherence to the fasting regimen.
During the fasting and refeeding periods, blood samples
were drawn daily between 0700 and 0900 (before breakfast
in the refeeding period). Samples were allowed to clot briefly
at room temperature, promptly centrifuged, and aliquots of
serum were submitted for measurement of potassium, bi-
carbonate, and blood urea nitrogen and stored at a -20'C
until assayed for somatomedin-C, insulin, and growth hor-
mone. Concentrations of immunoreactive somatomedin-C/
insulinlike growth factor I (11) were determined as previ-
ously described (5, 12). Selected pools of sera from study
subjects were chromatographed in 0.5 M acetic acid on a G-
50 Sephadex column (1.6 X 74 cm; LKB Instruments, Inc.,
Rockville, MD) which had been equilibrated in 0.5 M acetic
acid, pH 2.7. The fractions (4 ml each) eluting between a
distribution coefficient (Kd) of 0 and 0.85 were neutralized
with 0.2 ml of 10 N NaOH, and assayed for somatomedin-
C. Small molecular weight somatomedin-C stripped from its
binding proteins eluted between Kd 0.27 and 0.52, as de-
scribed by Zapf et al. (13). Serum insulin and growth hor-
mone concentrations were determined by radioimmunoassay
using purified porcine insulin (815-D63-10; kindly provided
by Dr. Mary Root, Eli Lilly & Co.) as standards and purified
human growth hormone (HS 2019G; provided by the Na-
tional Institute of Arthritis, Diabetes, Digestive and Kidney
Diseases, and the National Hormone and Pituitary Program
of the University of Maryland). 24-h urine collections were
obtained during the fasting and refeeding periods and were
submitted for autoanalyzer determinations of creatinine and
urea nitrogen (14, 15). Urinary ketones were determined by
the nitroprusside reaction (16).
Nitrogen balance was estimated by the following formula:
nitrogen balance = total nitrogen intake - (urinary urea ni-
trogen + 4 g) (17, 18). Student's t test was used in statistical
analysis of data, with significance defined at the 95% level.
Changes in nitrogen balance and somatomedin-C levels were
correlated using linear regression analysis.
RESULTS
Fasting and refeeding were carried out without sig-
nificant complications. One subject required the oral
administration of 3-6 g of sodium bicarbonate daily
during fasting to maintain serum bicarbonate> 13
meq/liter. Of the 15 fasts, 14 were accompanied by
ketonuria by the morning of the 2nd d, and in the
remaining fast the subject was ketonuric by the morn-
ing of the 3rd d. The mean weight loss during fasting
was 4.3±1.3 kg (±1 SD). The mean serum somato-
medin-C concentrations at the start and the end of
fasting were 1.85±0.39 U/ml (±1 SD)' and 0.67±0.15
U/ml, respectively (P < 0.005; Fig. 1).
Refeeding with isocaloric diets (-2,300 calories)
resulted in substantial increases in immunoreactive
somatomedin-C. The increase, however, was greater
when the subjects received the normal diet (0.56±0.07
U/ml; Fig. 1) than when they received the isocaloric,
protein-deficient diet (0.26±0.04 U/ml; Fig. 1). The
absolute difference between the two diets reached sta-
tistical significance by day 2 of refeeding (P < 0.01;
' Somatomedin-C levels vary during each decade of life
and are relatively higher in the second and third decades
than at any other time. The value of 1 U/ml of a standard
serum pool is assigned on the basis of the somatomedin-C
immunoreactivity of 220 normal adults, ages 18-64 yr. The
mean value of our study subjects (1.85 U/ml) is <1 SD above
the mean of 1.45 U/ml for adults ages 23-34 yr.
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FIGURE 1 Serum somatomedin-C during periods of fasting
and refeeding. Each point represents the mean±1 SD for the
five study subjects. Normal diet (-); low protein, isocaloric
diet (A); low protein, low energy diet (-).
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Fig. 1) and this difference remained relatively un-
changed through the 5th d. Refeeding with the diet
deficient in both protein and energy led to a further
decline in somatomedin-C (difference of means for all
patients, 0.37 U/ml). The mean difference in soma-
tomedin-C concentrations between this diet and the
normal energy, low protein diet was significant by day
3 of refeeding (0.18 U/ml, P < 0.01) and increased to
0.59 U/ml of day 5 (Fig. 1). The relative effects of
refeeding protein and energy are depicted graphically
in Fig. 2.
To rule out the possibility that the serum-binding
proteins for somatomedin-C were distorting the results
obtained in our radioimmunoassay (19), we prepared
three pools of serum taken from all five subjects before
fasting, at the end of 5 d of fasting, and after refeeding
with the normal diet for 5 d. These serum pools were
then chromatographed on Sephadex G-50 in 0.5 M
acetic acid. The immunoreactive somatomedin-C con-
tent of the acid-chromatographed serum pools and
nonacid chromatographed samples showed similar re-
lationships. Specifically, the nadir values at the end of
fasting were 36 and 40% of control in native and the
acid-chromatographed samples, respectively. The
samples at the end of refeeding were 70 and 91% of
the control in the native and the acid-chromato-














somatomedin-C measured in native serum provides a
reasonable approximation of that measured after acid
chromatography.
Although there were individual variations in the in-
crements of somatomedin-C with refeeding (Fig. 3),
responses in four of the five subjects reflect those of
the group as a whole for both of the normal energy
diets. In the remaining subject the somatomedin-C in-
crements were similar for both diets. This may reflect
the fact that this subject's caloric requirements were
greater while she was ingesting the normal diet, be-
cause she was engaging in unauthorized vigorous phys-
ical activity.
The mean daily nitrogen loss for all subjects during
fasting was 11.7±2.1 g/d. While refeeding a normal
diet, the daily estimated nitrogen balance became pos-
itive in all subjects with a mean nitrogen retention of
2.0 g/d. Nitrogen balance remained negative on the
low protein, isocaloric diet with a mean deficit of 2.9
g/d. On the diet deficient in both protein and energy
the mean nitrogen deficit was 5.2 g/d. Since somato-
medin stimulates protein synthesis in vitro, cumulative
changes in somatomedin-C levels and nitrogen balance
during refeeding were analyzed by linear regression.
Significant correlations were found for the normal diet
(r = 0.67, P < 0.001) (Fig. 4) and for the low protein,






FIGURE 2 Comparison of the effects of protein (left panel) and of energy (right panel) on
serum somatomedin-C during refeeding. Each point represents the percentage of control of
the mean prefast value. The effect of protein is depicted as the difference between the two
isocaloric diets. The effect of energy is the difference between the two protein-deficient diets.
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FIGURE 3 The response of each subject to refeeding the two normal energy diets. Somatomedin-
C is expressed as the percentage of control of the mean prefast value. One subject (0) was
engaged in vigorous physical activity while ingesting the normal diet.
relation was also found between changes in somato-
medin-C during each fasting or refeeding period and
mean daily nitrogen balance during that period (r
= 0.90; P < 0.001) (Fig. 5). When assessed in this man-









mild negative nitrogen balance, but a positive incre-
ment in serum somatomedin-C. This occurs in subjects
whose marked fasting-induced decline is followed by
a rise in somatomedin-C while being refed the low
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FIGURE 4 Correlation between the changes in somatomedin-C and nitrogen balance while
refeeding the normal diet. The change in somatomedin-C is the difference for each subject
between the value on the day of observation and the value at the end of fasting. The change
in nitrogen balance is the sum of the differences between each day of observation and the mean
daily loss during fasting. r = 0.67; P < 0.001.

















MEAN DAILY BALANCE (g)
+10
FIGURE 5 Correlation between somatomedin-C and nitrogen balance during all periods of
fasting and refeeding. The change in somatomedin-C is the total 5-d change over either the
fasting or refeeding periods. The mean daily nitrogen balance is the average daily nitrogen
balance for each subject over each 5-d study period. r = 0.90; P < 0.001.
trogen balance remains negative. When the magnitude
of change in somatomedin-C is compared with the
change in nitrogen stores during fasting and refeeding
of the normal diet, it is apparent that there are large
shifts in somatomedin-C compared with changes in
nitrogen stores (Table II). Somatomedin-C declines by
64% during fasting, while only 4% of total body ni-
trogen is lost. Refeeding a normal diet causes an 88%
increase in somatomedin-C, while only 17% of the
nitrogen lost during fasting is repleted.
To exclude the possibility that changes in serum so-
matomedin-C concentrations merely reflected changes
in other hormones, both fasting insulin and growth
hormone concentrations were determined for each day
of the study period. During each of the three 5-d fast-
ing periods, the mean basal insulin concentrations de-
clined from control values and this change was sig-
nificant during two periods (12.0±12.3 MU/ml to
TABLE II
Relationship between the Change in Somatomedin-C and the
Change in Total Body Nitrogen Stores
Fasting Refeeding
Somatomedin-C 64% decrease 88% increase
Total body nitrogen* 4% decrease 17% deficit restored
e Total body nitrogen estimates assume that the total body mass
is 16.4% protein (20).
2.2±1.7 gU/ml preceding the normal diet; and
11.3±13.3 to 3.2±2.0 MU/ml preceding the isocaloric,
low protein diet). During refeeding, fasting insulin
concentrations rose on all three diets by the end of the
first refeeding day, and remained relatively constant
thereafter. This increase was significant (from 2.2 up
to 7.1 uU/ml; P < 0.05) only for the normal diet. When
the changes in fasting insulin concentrations for each
fasting and refeeding period were correlated with the
mean daily nitrogen balance, the r value was 0.38 (P
< 0.05).
The mean serum growth hormone concentrations
showed a minimal increase (<3 ng/ml) during the first
3 d of each fasting period, then declined on the 4th
and 5th d. With refeeding, two subjects had suppres-
sion of fasting growth hormone values and three others
were unchanged. None of these changes reached sta-
tistical significance.
DISCUSSION
The decline in serum immunoreactive somatomedin-
C observed in normal weight subjects during fasting
confirms our previous results with obese subjects (6),
but is more accelerated. Since this decline occurs when
there has been little reduction in protein and fat stores,
there is reason to believe that the serum concentration
of this growth factor may be a sensitive indicator of
acute changes in nutritional status. Refeeding a normal







diet for 5 d resulted in the return of somatomedin-C
to 67% of prefast values. The rate of this rise in so-
matomedin-C was constant after the 1st d of refeeding.
After a 2-d delay, the isocaloric diet, which was de-
ficient in protein, also produced a comparable rate of
increase in somatomedin-C. In the presence of ade-
quate energy, therefore, optimal intake of protein ap-
pears to exert its greatest effect early in refeeding. The
2-d lag period may be the time required to reach a
new steady state of improved protein absorption and/
or utilization, a common adaptation to low protein-
adequate energy diets (21). Return of somatomedin-C
toward control levels following this period might re-
flect the body's more efficient utilization of a subnor-
mal dietary protein intake.
An adequate supply of energy appears to be essential
for the rise in somatomedin-C after fasting. This is
suggested by the finding that, compared with the rise
noted in subjects refed a low protein-adequate energy
diet (35 kcal/kg), feeding the diet in which energy
was restricted (10.8 kcal/kg) caused a further decline.
In keeping with our findings in humans, Phillips and
Vassiloupoulou-Sellin (22) have reported that refeed-
ing adequate energy to starved rats is necessary to
effect a sustained rise in somatomedin and that protein
deficiency results in only a transient increment in so-
matomedin activity. Prewitt et al. (8) have shown that
both protein and energy are important in maintaining
immunoreactive somatomedin-C in rats 12 or more
weeks old. In younger animals, protein appears to be
more important than energy in this regard, a finding
consistent with the age-dependent need for protein
(23). Our findings along with those of others (7), there-
fore, suggest that both protein and energy are needed
to restore somatomedin-C after fasting, and that a
minimum quantity of energy appears to be necessary
for this increase.
The strong correlations among cumulative changes
in somatomedin-C and cumulative changes in nitrogen
balance during refeeding, as well as the excellent cor-
relation between change in somatomedin-C and mean
daily nitrogen balance during fasting and refeeding,
provide further evidence that changes in somatome-
din-C reflect changes in protein metabolism. The find-
ing that some subjects were in mild negative nitrogen
balance during refeeding yet had positive increments
in somatomedin-C suggests that somatomedin-C cor-
relates best with acute directional changes in nitrogen
balance, rather than total body nitrogen stores. This
conclusion is reinforced by the data in Table II which
show that during fasting, somatomedin-C falls sub-
stantially at a time when nitrogen stores have changed
little, and with refeeding for 5 d somatomedin-C re-
turns to 68% of control levels at a time when relatively
little total nitrogen repletion has occurred. It is not
known whether the changes in somatomedin-C are
determining nitrogen balance, or simply reflect changes
in this process. Since somatomedin-C stimulates pro-
tein synthesis in a variety of tissues (24, 25), it is tempt-
ing to speculate that reduction in its serum concen-
trations could mediate a decrease in the rate of protein
synthesis.
Although there is remarkable homogeneity of our
subjects' somatomedin-C responses during refeeding,
two individuals varied from the typical response pat-
tern. One subject had a minimal somatomedin-C in-
crement when refed the normal diet. This may have
been due to increased caloric expenditure secondary
to an unauthorized increase in the level of physical
activity. In another subject there was evidence of a
high basal energy requirement (50 kcal/kg per d to
maintain weight). Nitrogen balance can be altered by
such variables as age (26), sex (27), basal metabolic
rate (28), body temperature (29), previous dietary in-
take (30), and changing energy expenditure during
refeeding (31). Since somatomedin-C appears to be a
very sensitive indicator of nutritional status, it is prob-
able that some of these variables can modify the so-
matomedin-C response to dietary manipulation.
Because dietary manipulation and nutritional status
influence secretion of several different hormones, the
possibility should be considered that the observed
changes in somatomedin-C might be secondary to al-
terations in other hormones. Insulin levels decline with
fasting and rise with refeeding (32, 33). In humans,
feeding a diet rich in protein but deficient in energy
is accompanied by low levels of insulin (34), suggesting
that energy may be the more important determinant
of insulin concentrations. Insulin levels correlate with
changes in nitrogen balance and play an important
role in regulating protein synthesis during nutritional
deprivation. The relationship between insulin and so-
matomedin in humans is less clear. Although soma-
tomedin production is increased by in vitro perfusion
of rat liver with insulin (35) there is no in vivo human
data to suggest that insulin administration alone, in
the absence of appropriate nutrients, can restore serum
somatomedin-C concentrations. Although it is possible
that in the presence of sufficient nutrients insulin may
facilitate somatomedin-C production, it seems doubt-
ful that the dramatic changes in somatomedin-C ob-
served in our subjects are caused by the minimal
changes in insulin. In fact, there was no significant
correlation between somatomedin-C and insulin dur-
ing fasting (r = 0.35) or refeeding the normal diet (r
= -0.22). It also appears unlikely that growth hormone
is directly involved in the modulation of the changes
in somatomedin-C, since the concentrations of these
two substances change in opposite directions with fast-
ing and refeeding. Furthermore, starvation causes
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growth hormone resistance, manifested by raised
serum growth hormone levels (2, 3) low serum so-
matomedin concentrations (2, 3), an inability of ad-
ministered growth hormone to raise serum somato-
medin (4), and peripheral resistance to the action of
growth hormone (4). The increases in cortisol (36) and
glucagon (37), which occur with starvation, also seem
to be unlikely modulators of somatomedin-C. Al-
though cortisol has been reported to reduce bioassay-
able somatomedin activity (38, 39), we have observed
that it does not affect immunoreactive somatomedin-
C (5).
Even though the mechanism(s) for the modulation
of somatomedin-C during fasting and refeeding and
the relationship of these changes to protein synthesis
and utilization remain undefined, our results suggest
that somatomedin-C could be an important modulator
of nutritional repletion following fasting. They also
raise the possibility that measurement of serum con-
centrations of this growth factor might be useful in
monitoring nutritional status of patients suffering from
diseases which affect absorption of nutrients or which
require nutritional support. Before these applications
can be utilized, however, further studies are needed
to determine the effect of acute and chronic illness on
somatomedin-C concentrations.
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